Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells
- PMID: 6719130
- DOI: 10.1126/science.6719130
Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells
Abstract
The ability of clonally derived lines of B16F1 and B16F10 melanoma cells to form experimental metastases in C57BL mice after intravenous injection was examined. Luria- Delbruck fluctuation analysis was applied to the results obtained with parallel subclones grown to small population sizes before testing for metastatic ability. The analysis demonstrated that variant cells capable of forming experimental metastases were generated in B16F1 cell populations at an effective rate of about 1.3 X 10(-5) per cell per generation while in B16F10 cell populations the effective rate of production was about 5 X 10(-5) per cell per generation. These results are consistent with a dynamic heterogeneity model of tumor progression. They suggest that the majority of cells in both lines are effectively nonmetastatic and that the higher metastatic ability of the B16F10 population may be due in part to a higher rate of generation of metastatic variants.
Similar articles
-
Dynamic heterogeneity: isolation of murine tumor cell populations enriched for metastatic variants and quantification of the unstable expression of the phenotype.Clin Exp Metastasis. 1986 Jul-Sep;4(3):153-76. doi: 10.1007/BF00117930. Clin Exp Metastasis. 1986. PMID: 3742890
-
Generation of drug-resistant variants in metastatic B16 mouse melanoma cell lines.Cancer Res. 1987 May 15;47(10):2604-8. Cancer Res. 1987. PMID: 3567893
-
Metastatic variants are generated spontaneously at a high rate in mouse KHT tumor.Proc Natl Acad Sci U S A. 1982 Sep;79(18):5547-51. doi: 10.1073/pnas.79.18.5547. Proc Natl Acad Sci U S A. 1982. PMID: 6957880 Free PMC article.
-
Quantitative genetic analysis of tumor progression.Cancer Metastasis Rev. 1985;4(2):173-92. doi: 10.1007/BF00050694. Cancer Metastasis Rev. 1985. PMID: 3893685 Review.
-
Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants.Cancer Metastasis Rev. 1982;1(2):99-140. doi: 10.1007/BF00048223. Cancer Metastasis Rev. 1982. PMID: 6764377 Review.
Cited by
-
Dynamic heterogeneity: experimental metastasis studies with RIF-1 fibrosarcoma.Clin Exp Metastasis. 1989 Jan-Feb;7(1):107-16. doi: 10.1007/BF02057185. Clin Exp Metastasis. 1989. PMID: 2908825
-
Disrupting ovarian cancer metastatic colonization: insights from metastasis suppressor studies.J Oncol. 2010;2010:286925. doi: 10.1155/2010/286925. Epub 2010 Mar 14. J Oncol. 2010. PMID: 20300552 Free PMC article.
-
AACR centennial series: the biology of cancer metastasis: historical perspective.Cancer Res. 2010 Jul 15;70(14):5649-69. doi: 10.1158/0008-5472.CAN-10-1040. Epub 2010 Jul 7. Cancer Res. 2010. PMID: 20610625 Free PMC article. Review.
-
Effect of anti-fibrinolytic therapy on experimental melanoma metastasis.Clin Exp Metastasis. 2009;26(2):121-31. doi: 10.1007/s10585-008-9221-z. Epub 2008 Dec 12. Clin Exp Metastasis. 2009. PMID: 19082867
-
Clonal dominance detected in metastases but not primary tumors of retrovirally marked human breast carcinoma injected into nude mice.Clin Exp Metastasis. 1994 Jan;12(1):3-12. doi: 10.1007/BF01784328. Clin Exp Metastasis. 1994. PMID: 8287617
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical